Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Diagnostic Biomarker Verification and Validation: A Cost-efficient, Speed to Market Adaptive Design Clinical Trial Model

Session Chair(s)

Alan J. Touch

Alan J. Touch

Chief Science Officer

Avodex Partners, United States

Clinical Trial Models for IVD Sample Collection and Human Factors Studies

Learning Objective : Discuss a cost-effective, time-sensitive sample collection protocol development using an adaptive clinical trial model that is aimed at establishment of the desired sensitivity and specificity algorithm for specific diagnostics continuing uninterrupted to a validation of use.

Speaker(s)

Alan J. Touch

Clinical Trial Models for IVD Sample Collection and Human Factors Studies

Alan J. Touch

Avodex Partners, United States

Chief Science Officer

Cari  DeLoa

A Data Collection Strategy to Improve the Effectiveness and Speed of the Companion Diagnostic and Therapeutic Product Co-Development Process

Cari DeLoa

Genentech, A Member of the Roche Group, United States

Principal Data Manager

João  Massud, MD

Future Outlooks for Imaging Clinical Trials in Latin America

João Massud, MD

Brazilian Society of Pharmaceutical Medicine (SBMF), Brazil

Senior Consultant, Drug Development

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.